91
Upper GI Handling of Branded vs. Generic Alendronate
Condition(s):OsteoporosisLast Updated:November 17, 2006Completed
FOSAMAX: 219 Clinical Trials, Page 10 of 22
Hide Studies Not Open or Pending
92
The Forteo Alendronate Comparator Trial
Condition(s):OsteoporosisLast Updated:April 14, 2015Completed
93
Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Condition(s):HIVLast Updated:April 19, 2018Completed
94
The Optimal Sequential Therapy After Long Term Denosumab Treatment
Condition(s):OsteoporosisLast Updated:October 25, 2021Recruiting
95
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)
Condition(s):Osteoporosis; HIV InfectionsLast Updated:December 22, 2011Completed
96
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Condition(s):OsteoporosisLast Updated:April 12, 2007Unknown status
97
Comparison of Alendronate With Atorvastatin in Chronic Periodontitis
Condition(s):Chronic PeriodontitisLast Updated:May 28, 2015Completed
98
Texture Analysis for Postmenopausal Osteoporosis
Condition(s):Osteoporosis; OsteopeniaLast Updated:September 11, 2018Completed
99
Romosozumab in Women With Chronic SCI
Condition(s):Osteoporosis; Bone Loss; Osteopenia, Osteoporosis; Spinal Cord Injuries; Chronic Spinal ParalysisLast Updated:January 11, 2023Active, not recruiting
100
A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
Condition(s):OsteoporosisLast Updated:March 31, 2022Not yet recruiting